Amikacin-Fresenius Injection
PDF Leaflet Revision Date: 04 December 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of serious nosocomial gram-negative bacillary infections.
Dosage (summary)
Adults: 15 mg/kg daily in divided doses every 8-12 hours; max 1.5 g/day.
Special Populations
- Renal impairment
- Elderly
- Neonates
Pregnancy & Breastfeeding
Not established; may harm fetus; use under supervision.
Key Drug Interactions
- Neurotoxic drugs
- Nephrotoxic drugs
- Cephalosporins
Contraindications
- Hypersensitivity to amikacin
- Pregnancy
- Myasthenia gravis
- Severe renal impairment
- Hearing impairment
Common side effects
- Ototoxicity
- Nephrotoxicity
- Nausea
- Vomiting
Counselling Points
- Stay hydrated during treatment
- Report hearing changes
- Do not double doses if missed
Serious warnings
- Nephrotoxicity risk
- Ototoxicity risk
- Monitor renal function
Important Disclaimer
The Amikacin-Fresenius Injection professional information leaflet below is the property of Fresenius Kabi and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
